Clearmind Medici Financials
This page shows Clearmind Medici (CMND) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Clearmind Medici passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass.
For every $1 of reported earnings, Clearmind Medici generates $1.23 in operating cash flow (-$4.7M OCF vs -$3.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Clearmind Medici reported -$3.9M in net income in fiscal year 2025. This represents an increase of 26.6% from the prior year.
Cash & Balance Sheet
Clearmind Medici held $9.3M in cash against $0 in long-term debt as of fiscal year 2025.
Clearmind Medici had 158,076 shares outstanding in fiscal year 2025.
Margins & Returns
Clearmind Medici's ROE was -46.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 137.3 percentage points from the prior year.
Capital Allocation
CMND Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | -$191K | N/A | $102K-81.2% | $544K+42443.9% | $1K | N/A | -$580K-234.3% | $432K |
| Income Tax | $4K | N/A | $8K-60.0% | $21K-47.5% | $39K | N/A | $43K+15.9% | $37K |
| Net Income | -$3.9M | N/A | N/A | N/A | -$1.1M | N/A | -$2.1M-130.6% | -$908K |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CMND Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.1M+83.2% | $6.1M+53.2% | $4.0M-23.4% | $5.2M-21.3% | $6.6M-9.2% | $7.3M-11.2% | $8.2M-7.6% | $8.8M |
| Current Assets | $11.0M+85.3% | $5.9M+55.6% | $3.8M-23.9% | $5.0M-21.7% | $6.4M-9.5% | $7.1M-11.3% | $8.0M-8.0% | $8.7M |
| Cash & Equivalents | $9.3M+136.0% | $3.9M+12.2% | $3.5M-21.8% | $4.5M-22.6% | $5.8M-12.1% | $6.6M-14.4% | $7.7M-7.5% | $8.3M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.9M-40.6% | $4.9M+68.4% | $2.9M+0.9% | $2.9M-22.8% | $3.7M-10.0% | $4.1M-11.8% | $4.7M+11.9% | $4.2M |
| Current Liabilities | $2.9M-40.6% | $4.9M+68.4% | $2.9M+0.9% | $2.9M-22.7% | $3.7M-9.9% | $4.1M-11.6% | $4.7M+11.3% | $4.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | $7K-57.9% | $16K-35.8% | $26K | N/A |
| Total Equity | $8.2M+590.8% | $1.2M+11.9% | $1.1M-53.7% | $2.3M-19.4% | $2.9M-8.2% | $3.1M-10.5% | $3.5M-25.2% | $4.6M |
| Retained Earnings | -$31.7M-13.8% | -$27.9M-2.5% | -$27.2M-5.1% | -$25.9M-3.1% | -$25.1M-4.5% | -$24.0M-3.8% | -$23.1M-10.0% | -$21.0M |
CMND Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.1M-62.1% | -$1.3M-18.5% | -$1.1M+1.2% | -$1.1M+13.2% | -$1.3M-17.5% | -$1.1M+4.4% | -$1.1M+5.5% | -$1.2M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | -$524K-564.3% | $113K+156.5% | -$200K-387.9% | $69K+119.8% | -$350K-1136.6% | $34K | N/A |
| Financing Cash Flow | $7.4M+231.3% | $2.2M+20807.0% | -$11K-5.0% | -$10K-102.5% | $405K+25.2% | $323K-31.2% | $470K+223.5% | $145K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CMND Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -46.8% | N/A | N/A | N/A | -37.5% | N/A | -60.3%-40.7pp | -19.6% |
| Return on Assets | -34.6% | N/A | N/A | N/A | -16.3% | N/A | -25.6%-15.3pp | -10.3% |
| Current Ratio | 3.79+2.6 | 1.22-0.1 | 1.32-0.4 | 1.74+0.0 | 1.720.0 | 1.720.0 | 1.71-0.4 | 2.07 |
| Debt-to-Equity | 0.35-3.7 | 4.10+1.4 | 2.72+1.5 | 1.25+1.2 | 0.000.0 | 0.010.0 | 0.01-0.9 | 0.90 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is Clearmind Medici profitable?
No, Clearmind Medici (CMND) reported a net income of -$3.9M in fiscal year 2025.
What is Clearmind Medici's return on equity (ROE)?
Clearmind Medici (CMND) has a return on equity of -46.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Clearmind Medici's operating cash flow?
Clearmind Medici (CMND) generated -$4.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Clearmind Medici's total assets?
Clearmind Medici (CMND) had $11.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Clearmind Medici's current ratio?
Clearmind Medici (CMND) had a current ratio of 3.79 as of fiscal year 2025, which is generally considered healthy.
What is Clearmind Medici's debt-to-equity ratio?
Clearmind Medici (CMND) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Clearmind Medici's return on assets (ROA)?
Clearmind Medici (CMND) had a return on assets of -34.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Clearmind Medici's cash runway?
Based on fiscal year 2025 data, Clearmind Medici (CMND) had $9.3M in cash against an annual operating cash burn of $4.7M. This gives an estimated cash runway of approximately 23 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Clearmind Medici's Piotroski F-Score?
Clearmind Medici (CMND) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Clearmind Medici's earnings high quality?
Clearmind Medici (CMND) has an earnings quality ratio of 1.23x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.